Daniel D’Andrea
University of Bristol · 72 works · 1,568 citations · h-index 20
Top works
- An expanded evaluation of protein function prediction methods shows an improvement in accuracy
- New encouraging developments in contact prediction: Assessment of the CASP 11 results
- FIDEA: a server for the functional interpretation of differential expression analysis
- Evaluation of residue–residue contact prediction in CASP10
- Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
- Novel Long Noncoding RNAs (lncRNAs) in Myogenesis: a miR-31 Overlapping lncRNA Transcript Controls Myoblast Differentiation
- Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity
- NF-κB in the crosshairs: Rethinking an old riddle
- Enhanced triacylglycerol catabolism by carboxylesterase 1 promotes aggressive colorectal carcinoma
- Genome-wide identification of direct HBx genomic targets
- A novel approach to simulate gene-environment interactions in complex diseases
- The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors
- GADD45β Loss Ablates Innate Immunosuppression in Cancer
- Foxm1 controls a pro-stemness microRNA network in neural stem cells
- m6A modification inhibits miRNAs’ intracellular function, favoring their extracellular export for intercellular communication
- Turning an old GADDget into a troublemaker
- CD28/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response
- Rapid Profiling of the Antigen Regions Recognized by Serum Antibodies Using Massively Parallel Sequencing of Antigen-Specific Libraries
- The actin modulator hMENA regulates GAS6‐AXL axis and pro‐tumor cancer/stromal cell cooperation
- Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer